What Happens If You Stop Wilson Disease Medication?
At a Glance
Stopping Wilson disease medication is extremely dangerous and can lead to fatal acute liver failure or irreversible brain damage within months to years. Because Wilson disease is a lifelong genetic condition, continuous treatment is required to prevent toxic copper buildup even if you feel healthy.
If you stop taking your Wilson disease medication, your body will rapidly resume storing toxic levels of copper. Even if you feel completely healthy today, discontinuing your pills will lead to a severe clinical relapse—most commonly acute liver failure or irreversible brain damage—typically within one to three years, and sometimes in as little as 8 to 12 months [1][2]. Wilson disease is a lifelong genetic condition. Feeling normal is proof that your medication is working, not a sign that you are cured [3][4].
These severe outcomes are entirely preventable by adhering to your prescribed treatment.
Missing a Dose vs. Stopping Treatment
It is important to understand the difference between accidentally missing a single pill and abandoning your maintenance therapy. Missing a single dose due to a pharmacy delay or a forgotten morning will not trigger immediate liver failure. If you miss a dose, simply take it as soon as you remember, or follow your doctor’s specific guidance (usually, you should skip it if it is almost time for your next dose). However, completely stopping your medication permanently ends your body’s protective balance and begins the dangerous process of copper re-accumulation.
The “Silent” Copper Re-accumulation
Your daily medication works by maintaining a negative copper balance [5][6]. Medications like D-penicillamine and trientine (chelators) force your body to excrete excess copper through urine, while zinc prevents your gut from absorbing copper from your food [7][8].
When you stop taking these pills, this protective balance ends. Because you still have the underlying genetic defect (mutations in the ATP7B gene), your liver starts hoarding copper again [9][10].
This process is “silent” at first. You will continue to feel normal while your liver absorbs the excess copper. Because you cannot feel this happening, attending your follow-up appointments for regular blood and urine tests is the only way your care team can monitor your copper levels.
Eventually, once your liver’s storage capacity is breached, the organ becomes overwhelmed and releases a massive flood of toxic free copper (copper not bound to protective proteins) into your bloodstream [11][2].
Severe Clinical Consequences
Once free copper floods your system, it damages your organs and red blood cells. The resulting clinical relapse often progresses much faster than your original Wilson disease symptoms.
Acute Liver Failure
A major physical threat is acute (fulminant) liver failure [12]. Patients can rapidly develop jaundice (yellowing of the skin and eyes), severe abdominal swelling, and a specific type of red blood cell destruction called hemolytic anemia [10]. Once this rapid liver failure begins, restarting your Wilson disease medication is rarely effective. At this stage, an urgent, life-saving liver transplant is usually the only treatment option [13][14].
Irreversible Brain Damage
If the copper floods your brain, it causes severe neuroinflammation [15]. This can trigger rapid-onset neurological symptoms, such as severe tremors, difficulty speaking or swallowing, muscle stiffness, and psychiatric episodes [16][17]. Unlike the slow progression of symptoms you might have experienced before diagnosis, neurological damage from a sudden relapse is often irreversible, even if you eventually restart therapy [18].
High Risk of Mortality
Medical literature demonstrates a very high risk for patients who abandon their maintenance therapy. Without treatment, Wilson disease is fatal [19]. In historical studies of asymptomatic patients who stopped taking their medication, the majority died from liver failure or neurological complications within three years [2].
What If You Have Already Stopped?
If you have already stopped taking your medication—whether a few weeks or months ago—contact your hepatologist or neurologist immediately. Do not wait until you feel sick. Your doctor can help you safely resume therapy and monitor your copper levels before permanent damage occurs.
Managing Medication Fatigue
It is incredibly common to experience “medication fatigue”—the frustrating, exhausting reality of taking pills every single day for a disease you can no longer feel.
To make your daily routine easier, consider using pill organizers, setting daily smartphone alarms, or “habit stacking” (tying your medication to a daily habit like brushing your teeth).
However, if your current regimen is still too difficult to maintain due to side effects, the number of pills, or scheduling around meals, speak with your doctor. They may be able to switch you to a different medication, adjust your dosing schedule, or simplify your routine while safely maintaining your copper balance [20][21].
Common questions in this guide
What should I do if I accidentally miss a dose of my Wilson disease medication?
Why do I still need medication for Wilson disease if I feel healthy?
What happens in the body when you stop taking Wilson disease pills?
What should I do if I already stopped taking my Wilson disease medication?
Can I switch my Wilson disease medication if I am experiencing side effects?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.If I am struggling with medication fatigue or side effects, are there alternative medications or dosing schedules we could explore?
- 2.What is my current level of non-ceruloplasmin bound (free) copper, and how well does it indicate my disease stability?
- 3.Can we review my 24-hour urinary copper excretion to ensure my current dosage is optimal?
- 4.If I accidentally miss a dose, what specific steps should I take regarding my schedule?
- 5.What specific emergency symptoms should my family and I watch for if my copper levels were to spike?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (21)
- 1
Pregnancy and Wilson disease: management and outcome of mother and newborns-experiences of a perinatal centre.
Reuner U, Dinger J
Annals of translational medicine 2019; (7(Suppl 2)):S56 doi:10.21037/atm.2019.04.40.
PMID: 31179293 - 2
Wilson disease.
Członkowska A, Litwin T, Dusek P, et al.
Nature reviews. Disease primers 2018; (4(1)):21 doi:10.1038/s41572-018-0018-3.
PMID: 30190489 - 3
Wilson disease in Northern Portugal: a long-term follow-up study.
Garrido I, Marques M, Liberal R, et al.
Orphanet journal of rare diseases 2022; (17(1)):82 doi:10.1186/s13023-022-02245-5.
PMID: 35197085 - 4
Hepatic features of Wilson disease.
Boga S, Ala A, Schilsky ML
Handbook of clinical neurology 2017; (142()):91-99 doi:10.1016/B978-0-444-63625-6.00009-4.
PMID: 28433114 - 5
Brain copper storage after genetic long-term correction in a mouse model of Wilson disease.
Uerlings R, Moreno D, Murillo O, et al.
Neurology. Genetics 2018; (4(3)):e243 doi:10.1212/NXG.0000000000000243.
PMID: 29845115 - 6
Wilson disease - currently used anticopper therapy.
Członkowska A, Litwin T
Handbook of clinical neurology 2017; (142()):181-191 doi:10.1016/B978-0-444-63625-6.00015-X.
PMID: 28433101 - 7
Wilson Disease: Copper-Mediated Cuproptosis, Iron-Related Ferroptosis, and Clinical Highlights, with Comprehensive and Critical Analysis Update.
Teschke R, Eickhoff A
International journal of molecular sciences 2024; (25(9)) doi:10.3390/ijms25094753.
PMID: 38731973 - 8
Wilson's disease- management and long term outcomes.
Socha P, Czlonkowska A, Janczyk W, Litwin T
Best practice & research. Clinical gastroenterology 2022; (56-57()):101768 doi:10.1016/j.bpg.2021.101768.
PMID: 35331405 - 9
Ocular manifestations of Wilson's disease.
Goel S, Sahay P, Maharana PK, Titiyal JS
BMJ case reports 2019; (12(3)) doi:10.1136/bcr-2019-229662.
PMID: 30846461 - 10
Liver Transplantation in Adults With Wilson's Disease for the Neuropsychiatric Phenotype: Are We There Yet?
Abdallah MA, Singal AK
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2020; (26(4)):485-486 doi:10.1002/lt.25727.
PMID: 32031727 - 11
Therapeutic strategies in Wilson disease: pathophysiology and mode of action.
Stremmel W, Weiskirchen R
Annals of translational medicine 2021; (9(8)):732 doi:10.21037/atm-20-3090.
PMID: 33987430 - 12
Diagnostic Dilemma and Treatment Outcome in Acute Liver Failure Due to Wilson's Disease.
Stankiewicz R, Patkowski W, Zieniewicz K
Annals of transplantation 2021; (26()):e930146 doi:10.12659/AOT.930146.
PMID: 34001844 - 13
Liver transplantation for late-onset presentations of acute liver failure in Wilson's disease: The UK experience over 2 decades.
Shribman S, Webb G, Taylor R, et al.
JHEP reports : innovation in hepatology 2020; (2(3)):100096 doi:10.1016/j.jhepr.2020.100096.
PMID: 32322813 - 14
Fourteen Years of Experience of Liver Transplantation for Wilson's Disease; a Report on 107 Cases from Shiraz, Iran.
Lankarani KB, Malek-Hosseini SA, Nikeghbalian S, et al.
PloS one 2016; (11(12)):e0167890 doi:10.1371/journal.pone.0167890.
PMID: 27930723 - 15
Inflammatory cytokines expression in Wilson's disease.
Wu P, Dong J, Cheng N, et al.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2019; (40(5)):1059-1066 doi:10.1007/s10072-018-3680-z.
PMID: 30644005 - 16
Neurologic impairment in Wilson disease.
Dusek P, Litwin T, Członkowska A
Annals of translational medicine 2019; (7(Suppl 2)):S64 doi:10.21037/atm.2019.02.43.
PMID: 31179301 - 17
Analysis of risk factors for neurological symptoms in patients with purely hepatic Wilson's disease at diagnosis.
Diao SP, Zhuang YS, Huang YQ, et al.
BMC neurology 2023; (23(1)):89 doi:10.1186/s12883-023-03105-w.
PMID: 36855079 - 18
Other organ involvement and clinical aspects of Wilson disease.
Dzieżyc K, Litwin T, Członkowska A
Handbook of clinical neurology 2017; (142()):157-169 doi:10.1016/B978-0-444-63625-6.00013-6.
PMID: 28433099 - 19
The dilemma to diagnose Wilson disease by genetic testing alone.
Stättermayer AF, Entenmann A, Gschwantler M, et al.
European journal of clinical investigation 2019; (49(8)):e13147 doi:10.1111/eci.13147.
PMID: 31169307 - 20
Long-term outcome of neurological Wilson's disease.
Hefter H, Tezayak O, Rosenthal D
Parkinsonism & related disorders 2018; (49()):48-53 doi:10.1016/j.parkreldis.2018.01.007.
PMID: 29331561 - 21
Switching Pharmacological Treatment in Wilson Disease: Case Report and Recommendations.
Leung M, Wu Lanzafame J, Medici V
Journal of investigative medicine high impact case reports 2020; (8()):2324709619896876 doi:10.1177/2324709619896876.
PMID: 31920114
This page provides educational information about Wilson disease medication adherence. It is not medical advice. Always consult your hepatologist or neurologist before making any changes to your prescribed treatment plan.
Get notified when new evidence is published on Wilson disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.